Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

Cleo Diagnostics (ASX:COV) Surges on Development and commercial preparation for its ovarian cancer diagnostic technology

• Cleo Diagnostics Ltd is progressing development and commercial preparation for its ovarian cancer diagnostic technology.

Aditi Sarkar | 22 September 2026

Micro-X (ASX:MX1) Rises as CT Development and Research Programs Stay in Focus

• The company secured AUD 1.3mn for research related to its lung CT scanner program.

Aditi Sarkar | 22 September 2026

Trajan Group Holdings (ASX:TRJ) Rises as FY26 Reset Puts Operations Back in Focus

• The company has been implementing operational initiatives across its global analytical and life-science businesses.

Aditi Sarkar | 22 September 2026

Avecho Biotechnology (ASX:AVE) Advances as Phase III Insomnia Trial Enters Final Recruitment Stage

• Avecho has recommenced recruitment for the second and final cohort of its pivotal Phase III insomnia trial.

Aditi Sarkar | 22 September 2026

Could Medibank Private (ASX:MPL) Be Worth Watching After Its FY26 Underlying Profit Rose 2.9%?

Medibank is one of Australia's largest private health insurers, operating under the Medibank and ahm brands, and also provides health services through its Medibank Health division, which includes Amplar Health and general practice clinics.

Sonal Goyal | 22 September 2026

Should You Keep Ramsay Health Care (ASX:RHC) Stock on Your Watchlist After Its FY26 NPAT Rose 19%?

Ramsay Health Care is a global hospital operator with businesses in Australia, the United Kingdom and Europe, including its Elysium mental health and neurological careBusinessand a majority stake in Ramsay Santé, its European operations.

Sonal Goyal | 22 September 2026

Why Is TrivarX (ASX:TRI) Stock Facing Selling Pressure Today?

According to the Appendix 4E lodged for the reporting period ended 30 June 2026, TrivarX reported revenues from ordinary activities of $14,566, compared with $1,128,979 in the previous corresponding period, a decrease of 98.71%. Total comprehensive loss attributable to members was $8,915,118, compared with …

Sonal Goyal | 22 September 2026

Why Is Careteq (ASX:CTQ) Stock Under Pressure Today?

Recently, the company reported total revenue and other income from continuing operations of $6.90 million in FY26, compared with $8.32 million in FY25, a decrease of $1.42 million. Revenue from contracts with customers was $6.08 million, down from $7.62 million in the prior year. …

Sonal Goyal | 22 September 2026

Why Is IDT Australia (ASX:IDT) Stock Facing Selling Pressure Today?

Recently, the company reported EBITDA improving 85% year-on-year to -$922,000, with ordinary revenue from its three core verticals increasing 16.5% year-on-year to $16.8 million, up from $14.4 million in FY25. Total revenue for the period was $20.4 million, 3.1% ahead of the previous year, …

Sonal Goyal | 22 September 2026

Trajan Group Holdings (ASX:TRJ) Shares Rise on Tuesday – Here’s What Happening

The Company noted that Australian dollar appreciation in H2 FY26 impacted reported earnings by approximately $5.0 million in revenue and $2.4 million in nEBITDA, as previously flagged in a May 2026 trading update. Excluding this foreign exchange impact in H2, revenue and nEBITDA were …

Sonal Goyal | 22 September 2026
Support

Hi! How can we help you today?

Loading…